Literature DB >> 8825012

High seroprevalence of parvovirus B19 among patients infected with human immunodeficiency virus.

P L Vernazza, L A Pfister, G Siegl, P Cassinotti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8825012     DOI： 10.1093/clinids/22.1.198-a

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  The human parvovirus B19/human immunodeficiency virus co-infection in healthy eligible voluntary blood donors at the Blood Transfusion National Center in Kinshasa.

Authors:  Chabo Byaene Alain; Lufimbo Katawandja Antoine; Bizeti Nsangu Bizette; Pambu Dahlia; Tshibuela Beya Dophie; Muwonga Masidi Jérémie; Kayembe Nzongola-Nkasu Donatien; Ahuka Mundeke Steve
Journal:  Pan Afr Med J       Date:  2020-03-10

2.  Parvovirus B19 DNA detection in treatment-naïve HIV anemic patients in Lagos, Nigeria: a case control study.

Authors:  Oluwaseyi Sedowhe Ashaka; Olumuyiwa Babalola Salu; Ayorinde Babatunde James; Akeeb Oriowo Bola Oyefolu; AbdulAzeez Adeyemi Anjorin; Bamidele Oludare Oke; Mercy Remilekun Orenolu; Sunday Aremu Omilabu
Journal:  Afr Health Sci       Date:  2020-03       Impact factor: 0.927

3.  Status of immunity against PVB19 in HIV-infected patients according to CD4(+) cell count, and antiretroviral therapy regimen groups.

Authors:  Alireza Abdollahi; Saeed Shoar; Sara Sheikhbahaei; Behnaz Mahdaviani; Mehrnaz Rasoulinejad
Journal:  Niger Med J       Date:  2014-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.